{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T22:36:41Z","timestamp":1774305401597,"version":"3.50.1"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2012,7,13]],"date-time":"2012-07-13T00:00:00Z","timestamp":1342137600000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0040074","type":"journal-article","created":{"date-parts":[[2012,7,14]],"date-time":"2012-07-14T05:04:21Z","timestamp":1342242261000},"page":"e40074","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Sustained Exendin-4 Secretion through Gene Therapy Targeting Salivary Glands in Two Different Rodent Models of Obesity\/Type 2 Diabetes"],"prefix":"10.1371","volume":"7","author":[{"given":"Giovanni","family":"Di Pasquale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ilaria","family":"Dicembrini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Raimondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josephine M.","family":"Egan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Cinci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Loreto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Manni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Berretti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annamaria","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changyu","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Drew G.","family":"Michael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Vettor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A.","family":"Chiorini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edoardo","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo M.","family":"Rotella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,7,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1017\/S146239940900132X","article-title":"Molecular mechanisms underlying nutrient-stimulated incretin secretion.","volume":"12","author":"HE Parker","year":"2010","journal-title":"Expert Rev Mol Med"},{"key":"ref2","first-page":"889","article-title":"Targeting GLP-1 release as a potential strategy for the therapy of Type 2 diabetes.","volume":"25(8)","author":"FM Gribble","year":"2008","journal-title":"Diabet Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1046\/j.1464-5491.2000.00367.x","article-title":"Glucagon-like peptide (GLP)-1 and leptin concentrations in obese patients with Type 2 diabetes mellitus.","volume":"17(10)","author":"E Mannucci","year":"2000","journal-title":"Diabet Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.2337\/diabetes.50.3.609","article-title":"Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.","volume":"50(3)","author":"T Vilsb\u00f8ll","year":"2001","journal-title":"Diabetes"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(02)07952-7","article-title":"Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study.","volume":"359(9309)","author":"M Zander","year":"2002","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1331\/JAPhA.2009.09078","article-title":"Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.","volume":"49","author":"JJ Neumiller","year":"2009","journal-title":"J Am Pharm Assoc"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.beem.2009.03.008","article-title":"Exenatide and liraglutide: different approaches to develop GLP-1 receptor agonists (incretin mimetics)\u2013preclinical and clinical results.","volume":"23(4)","author":"S Madsbad","year":"2009","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"898913","DOI":"10.1155\/2011\/898913","article-title":"From theory to clinical practice in the use of GLP-1 receptor agonists and DPP-4 inhibitors therapy.","volume":"2011","author":"I Dicembrini","year":"2011","journal-title":"Exp Diabetes Res"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/jcb.21819","article-title":"Adeno-associated virus-mediated gene transfer.","volume":"105(1)","author":"A Srivastava","year":"2008","journal-title":"J Cell Biochem"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1210\/en.2010-0193","article-title":"Systemic delivery of bioactive glucagon-like peptide 1 after adenoviral-mediated gene transfer in the murine salivary gland.","volume":"151(9)","author":"A Voutetakis","year":"2010","journal-title":"Endocrinology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/sj.gt.3302836","article-title":"Gene therapy of diabetes using a novel GLP-1\/IgG1-Fc fusion construct normalizes glucose levels in db\/db mice.","volume":"14(2)","author":"M Kumar","year":"2007","journal-title":"Gene Ther"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.bbrc.2010.10.131","article-title":"A site-specific genomic integration strategy for sustained expression of glucagon-like peptide-1 in mouse muscle for controlling energy homeostasis.","volume":"403(2)","author":"R Liu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/mt.2008.198","article-title":"Gene therapy for diabetes: metabolic effects of helper-dependent adenoviral exendin 4 expression in a diet-induced obesity mouse model.","volume":"16(11)","author":"SL Samson","year":"2008","journal-title":"Mol Ther"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jgm.1153","article-title":"Adenoviral vector-mediated glucagon-like peptide 1 gene therapy improves glucose homeostasis in Zucker diabetic fatty rats.","volume":"10(3)","author":"Y Lee","year":"2008","journal-title":"J Gene Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ymthe.2005.03.039","article-title":"Glucagon-like peptide-1 plasmid construction and delivery for the treatment of type 2 diabetes.","volume":"12(5)","author":"S Choi","year":"2005","journal-title":"Mol Ther"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.2337\/db06-1182","article-title":"Glucagon-like peptide-1 gene therapy in obese diabetic mice results in long-term cure of diabetes by improving insulin sensitivity and reducing hepatic gluconeogenesis.","volume":"56(6)","author":"YS Lee","year":"2007","journal-title":"Diabetes"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"601047","DOI":"10.1155\/2011\/601047","article-title":"Glucagon-like peptide-1 gene therapy.","volume":"2011","author":"AM Rowzee","year":"2011","journal-title":"Exp Diabetes Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1038\/sj.gt.3302815","article-title":"Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways.","volume":"13(24)","author":"SG Sumner-Jones","year":"2006","journal-title":"Gene Ther"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ymthe.2005.12.001","article-title":"Long-term doxycycline-regulated transgene expression in the retina of nonhuman primates following subretinal injection of recombinant AAV vectors.","volume":"13(5)","author":"K Stieger","year":"2006","journal-title":"Mol Ther"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1182\/blood-2008-10-181479","article-title":"Long-term correction of inhibitor-prone hemophilia B dogs treated with liver-directed AAV2-mediated factor IX gene therapy.","volume":"113(4)","author":"GP Niemeyer","year":"2009","journal-title":"Blood"},{"issue":"21(4)","key":"ref21","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/CMR.00008-08","article-title":"Gene therapy using adeno-associated virus vectors.","volume":"Rev","author":"S Daya","year":"2008","journal-title":"Clin Microbiol"},{"key":"ref22","first-page":"240","article-title":"CERE-110, an adeno-associated virus-based gene delivery vector expressing human nerve growth factor for the treatment of Alzheimer\u2019s disease.","volume":"12(2)","author":"RJ Mandel","year":"2010","journal-title":"Curr Opin Mol Ther"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1056\/NEJMoa0802268","article-title":"Effect of gene therapy on visual function in Leber\u2019s congenital amaurosis.","volume":"358(21)","author":"JW Bainbridge","year":"2008","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1378\/chest.125.2.509","article-title":"Repeated adeno-associated virus serotype 2 aerosol-mediated cystic fibrosis transmembrane regulator gene transfer to the lungs of patients with cystic fibrosis: a multicenter, double-blind, placebo-controlled trial.","volume":"125(2)","author":"RB Moss","year":"2004","journal-title":"Chest"},{"key":"ref25","first-page":"813","article-title":"NLX-P101, an adeno-associated virus gene therapy encoding glutamic acid decarboxylase, for the potential treatment of Parkinson\u2019s disease.","volume":"11(7)","author":"J Diaz-Nido","year":"2010","journal-title":"Curr Opin Investig Drugs"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/mt.2009.277","article-title":"Gene therapy for Leber\u2019s congenital amaurosis is safe and effective through 1.5 years after vector administration.","volume":"18(3)","author":"F Simonelli","year":"2010","journal-title":"Mol Ther"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11095-007-9431-0","article-title":"Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer.","volume":"25(3)","author":"I Kwon","year":"2008","journal-title":"Pharm Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/sj.gt.3302691","article-title":"Enhanced transduction of mouse salivary glands with AAV5-based vectors.","volume":"13(7)","author":"H Katano","year":"2006","journal-title":"Gene Ther"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1677\/joe.1.06171","article-title":"Salivary glands as a potential gene transfer target for gene therapeutics of some monogenetic endocrine disorders.","volume":"185(3)","author":"A Voutetakis","year":"2005","journal-title":"J Endocrinol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/sj.gt.3300622","article-title":"Systemic action of human growth hormone following adenovirus-mediated gene transfer to rat submandibular glands.","volume":"5(4)","author":"X He","year":"1998","journal-title":"Gene Ther"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/hum.2010.097","article-title":"Human parathyroid hormone is secreted primarily into the bloodstream after rat parotid gland gene transfer.","volume":"22(1)","author":"J Adriaansen","year":"2011","journal-title":"Hum Gene Ther"},{"key":"ref32","article-title":"Gene delivery in salivary glands: From the bench to the clinic. Biochimica et Biophysica Acta.","author":"Y Samani","year":"2011"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.ymthe.2005.02.004","article-title":"A novel bovine virus efficiently transduces inner ear neuroepithelial cells.","volume":"11(6)","author":"G Di Pasquale","year":"2005","journal-title":"Mol Ther"},{"key":"ref34","first-page":"475","article-title":"Retrovirus-mediated expression of an artificial beta-endorphin precursor in primary fibroblasts. J Neurochem.","volume":"64(2)","author":"AS Beutler","year":"1995"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1210\/endo.142.10.8410","article-title":"Insertion of an N-terminal 6-aminohexanoic acid after the 7 amino acid position of glucagon-like peptide-1 produces a long-acting hypoglycemic agent.","volume":"142(10)","author":"ME Doyle","year":"2001","journal-title":"Endocrinology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1258\/la.2010.009114","article-title":"Weight gain in response to high-fat feeding in CD-1 male mice.","volume":"44(3)","author":"WL Breslin","year":"2010","journal-title":"Lab Anim"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/j.metabol.2005.02.016","article-title":"Physiological difference between obese (fa\/fa) Zucker rats and lean Zucker rats concerning adiponectin.","volume":"54(8)","author":"F Oana","year":"2005","journal-title":"Metabolism"},{"key":"ref38","first-page":"835","article-title":"Deposition of docohexaenoic acid (DHA) is limited in forebrain of young obese fa\/fa Zucker rats fed a dier high in \u03b1-linoleic acid but devoid of DHA.","volume":"22","author":"J Zhao","year":"2011","journal-title":"Journal of Nutritional Chemistry"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1007\/BF03347560","article-title":"Glucagon-like peptide 1 (GLP-1) and metabolic diseases.","volume":"28(8)","author":"CM Rotella","year":"2005","journal-title":"J Endocrinol Invest"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1530\/EJE-09-0101","article-title":"Glucagon-like peptide-1 receptor agonists in type 2 diabetes: a meta-analysis of randomized clinical trials.","volume":"160(6)","author":"M Monami","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0140-6736(09)61375-1","article-title":"NN8022-1807 Study Group. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study.","volume":"374(9701)","author":"A Astrup","year":"2009","journal-title":"Lancet"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2337\/diab.43.4.535","article-title":"Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide 1 in humans.","volume":"43(4)","author":"C Orskov","year":"1994","journal-title":"Diabetes"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/dc06-2375","article-title":"Effects of once-weekly dosing of a long-acting release formulation of exenatideon glucose control and body weight in subjects with type 2 diabetes.","volume":"30(6)","author":"D Kim","year":"2007","journal-title":"Diabetes Care"},{"key":"ref44","first-page":"1473","article-title":"Glucagon-like Peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. Endocrinology.","volume":"151(4)","author":"LB Knudsen","year":"2010"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0040074","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,30]],"date-time":"2019-06-30T23:08:13Z","timestamp":1561936093000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0040074"}},"subtitle":[],"editor":[{"given":"Miguel","family":"L\u00f3pez","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,7,13]]},"references-count":44,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2012,7,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0040074","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,13]]}}}